Ukr.Biochem.J. 2017; Volume 89, Issue 5, Sep-Oct, pp. 117-123

doi: https://doi.org/10.15407/ubj89.05.117

Scientific and practical activity of the Laboratory of Cell Signaling Mechanisms of the Palladin Institute of Biochemistry of NAS of Ukraine

R. P. Vynogradova, I. Yu. Chernysh, V. M. Danilova

Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv;
e-mail: valdan@biochem.kiev.ua

The article is devoted to the analysis of the scientific and practical activity of the laboratory of the signaling mechanisms of the cells of the Palladin Institute of Biochemistry, NAS of Ukraine, in the context of the history of its development. The most important results of studies of the mechanisms controlling proliferation, migration and invasion of tumor cells, which testify to the important role of the Ruk/CIN85 adapter protein in carcinogenesis, are presented. These studies are a priority and can serve as an experimental basis for the development of new generation pharmacological agents, the targets for which can be key centers for the organization of signaling systems of the cell – adapter and scaffold proteins.

Keywords: , , , ,


References:

  1. Drobot LB. Laboratory of cell signaling. Palladin Institute of Biochemistry. National Academy of Sciences of Ukraine. Kiyv, 2015. P. 135-148.
  2. Mayevska O, Shuvayeva H, Igumentseva N, Havrylov S, Basaraba O, Bobak Y, Barska M, Volod’ko N, Baranska J, Buchman V, Drobot L. Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma. Exp Oncol. 2006 Dec;28(4):275-81. PubMed
  3. Bobak Ya, Basaraba O, Shuvayeva G., Mayevska O, Ihumentseva N, Vynnytska B, Fedorko O, Drobot L. Study of CIN85/Ruk isoforms expression in human glyoblastoma multiforme. Annales Universitatis Mariae Curie–Sklodowska Lublin–Polonia, 2006; LXIX(1), 38: 183-185.
  4. Basaraba OI, Bobak YaP, Shuvayeva HYu, Marchenko SM, Mayevska OM, Ihumentseva N., Volodko NA, Bukhman VP, Drobot LB. Study of adapter proteins Ruk/CIN85 and CD2AP/CMS expression in human uterus tumors. Med Chem. 2009; 11(3): 9-12.
  5. Samoylenko A, Dimova EY, Kozlova N, Drobot L, Kietzmann T. The adaptor protein Ruk/CIN85 activates plasminogen activator inhibitor-1 (PAI-1) expression via hypoxia-inducible factor-1alpha. Thromb Haemost. 2010 May;103(5):901-9. PubMed, CrossRef
  6. Samoylenko AA. The role of hypoxia-inducible factor family (HIF) proteins in the regulation of cells physiologic responses to hypoxia. Ukr Biokhim Zhurn. 2010 Jul-Aug;82(4):5-17. (In Ukrainian). PubMed
  7. Samoylenko AA. Enhancement of the expression of adaptor protein Ruk/CIN85 in MCF-7 cells under the action of insulin and IGF-1. Dopov Nac Acad Nauk Ukr. 2011; (4): 158-162.
  8. Samoylenko A, Vynnytska-Myronovska B, Byts N, Kozlova N, Basaraba O, Pasichnyk G, Palyvoda K, Bobak Y, Barska M, Mayevska O, Rzhepetsky Y, Shuvayeva H, Lyzogubov V, Usenko V, Savran V, Volodko N, Buchman V, Kietzmann T, Drobot L. Increased levels of the HER1 adaptor protein Rukl/CIN85 contribute to breast cancer malignancy. Carcinogenesis. 2012 Oct;33(10):1976-84. PubMed, CrossRef
  9. Drobot LB, Samoylenko AA, Vorotnikov AV, Tyurin-Kuzmin PA, Bazalii AV, Kietzmann T, Tkachuk VA, Komisarenko SV. Reactive oxygen species in signal transduction. Ukr Biokhim Zhurn. 2013; 85(6): 209-217. CrossRef
  10. Vynnytska-Myronovska BO, Bobak YP, Pasichnyk GV, Igumentseva NI, Samoylenko AA, Drobot LB. Multiple molecular forms of adaptor protein Ruk/CIN85 specifically associate with different subcellular compartments in human breast adenocarcinoma MCF-7 cells. Ukr Biochem J. 2014 Sep-Oct;86(5):102-10. PubMed, CrossRef
  11. Samoylenko AA, Byts NV, GV Pasichnyk, Kozlova NV, Bazalii AV, Gerashchenko DS, Shandrenko SG, Vorotnikov AV, Kietzmann T, Komisarenko SV, Drobot LB. Recombinant lentivirus-mediated silencing of adaptor protein RuK/CIN85 expression influences biological responses of tumor cells. Biotechnol Acta. 2013; 6(4): 182-189.  CrossRef
  12. Pasichnyk GV, Povorozniuk OО, Gorak IR, Gerashchenko DS, Ponomarenko OV, Samoylenko AA, Byts NV, Drobot LB. Overexpression of adaptor protein Rukl/CIN85 in human breast adenocarcinoma cell line MCF-7 is accompanied by increased chemoresistance. Dopov Nac Acad Nauk Ukr. 2013; (12): 149-156.
  13. Bazalii AV, Samoylenko AA, Petukhov DM, Rynditch AV, Redowicz M-J, Drobot LB. Interaction between adaptor proteins Ruk/CIN85 and Tks4 in normal and tumor cells of different tissue origins. Biopolym Cell. 2014; 30(1): 37-41.  CrossRef
  14. Bazalii AV, Horak IR, Pasichnyk GV,  Komisarenko CV, Drobot LB. Transcriptional regulation of NOX genes expression in human breast adenocarcinoma MCF-7 cells is modulated by adaptor protein Ruk/CIN85. Ukr Biochem J. 2016; 88(1): 119-125. CrossRef
  15. Bazalii AV, Drobot LB, Komisarenko SV. Apocynin attenuates motility and induces transition from sustained to transient EGE-dependent Akt activation in MCF-7 cells that overexpress adaptor protein Ruk/CIN85. Biopolym Cell. 2016; 32(1): 21-25.  CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.